Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
07/2003
07/24/2003US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/24/2003US20030138664 Light emitting device material, light emitting device using thereof, and amine compound
07/24/2003US20030138662 A dibenzoquinoxaline compounds electron transporting materials; flat-panel display, electroluminescence
07/24/2003CA2473362A1 Substituted alkyl uracils and the use thereof
07/24/2003CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003CA2472469A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003CA2471620A1 Pyrrolidone carboxamides
07/24/2003CA2471311A1 Aromatic thioether liver x-receptor modulators
07/24/2003CA2469435A1 Modulators of lxr
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003CN1432013A Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
07/23/2003CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
07/23/2003CN1432009A Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
07/23/2003CN1432000A TNF-alpha prodn. inhibitors
07/23/2003CN1431997A 2-acyl indol derivatives and their use as anti-tumour agents
07/23/2003CN1431904A Protease inhitors
07/23/2003CN1115341C Substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
07/22/2003US6596876 Prostaglandin I2 inhibitors
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/22/2003US6596754 Preventives/remedies for multiple organ failure
07/22/2003US6596749 Neuropeptide y receptor ligand
07/22/2003US6596746 Cyclic protein tyrosine kinase inhibitors
07/22/2003US6596743 Carbamic acid derivatives
07/22/2003US6596737 C10 carbamoyloxy substituted taxanes
07/22/2003US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients
07/22/2003US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides
07/22/2003US6596718 7-Morpholin-4yl-benzothiazole amide derivatives
07/22/2003US6596716 2-propane-sulphonamide derivatives
07/22/2003CA2228572C Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
07/17/2003WO2003058667A1 Organic light-emitting devices
07/17/2003WO2003057689A1 Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
07/17/2003WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
07/17/2003WO2003057669A1 Androgen receptor antagonists
07/17/2003WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use
07/17/2003WO2003057666A2 Inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
07/17/2003WO2003057213A2 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057212A1 Polyamide derivatives possessing antibacterial, antifungal or antitumor activity
07/17/2003WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols
07/17/2003WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression
07/17/2003WO2002085861A8 Imidazolidine compounds and their use as cxcr3 antagonists
07/17/2003WO2002055496A8 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
07/17/2003US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate
07/17/2003US20030135048 Predominantly cis nucleosides or nucleoside analogues and derivatives from 2-oxymethyl- thiolane-S-oxide, oxathiolane-S-oxide or dithiolane-S-oxide and a pyridine, pyrimidine or triazine base
07/17/2003US20030135044 Novel gamma secretase inhibitors
07/17/2003US20030134886 Pharmaceutically active compounds
07/17/2003US20030134880 Novel cd23 inhibitors
07/17/2003US20030134853 Tetrazolyl- and carbamidosulfonyl-substituted 2-phenyl-1-cycloalkyl -benzimidazoles or -imidazo(4,5b)pyridines that inhibit the RNA-dependent RNA polymerase encoded by Hepatitis C
07/17/2003US20030134840 Novel compounds
07/17/2003US20030134836 Substituted arylamine derivatives and methods of use
07/17/2003US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
07/17/2003US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
07/17/2003US20030134748 Insecticial 3-(2,6-disubstituted phenyl)-5-[4- or 5-arylthien-2- or -3-yl]-1,2,4-triazoles
07/17/2003US20030134148 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
07/17/2003CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
07/17/2003CA2471754A1 Androgen receptor antagonist
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/16/2003EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
07/16/2003EP1327629A1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses
07/16/2003EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
07/16/2003EP1326858A2 Piperidine compounds as anti-allergic
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
07/16/2003EP1326843A1 Pyrazole derivatives for the treatment of viral diseases
07/16/2003EP1326830A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
07/16/2003EP1326829A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
07/16/2003EP1224182B1 N-substituted 1-(butyrolactone)-isoquinolines for treating nervous disorders
07/16/2003EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them
07/16/2003CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1114603C Hydrazono-1,3-dithiocyclopentane derivative and synthesizing method thereof
07/16/2003CN1114602C Ketone derivatives and medicinal use thereof
07/16/2003CN1114594C D4 receptor selectivity piperazine derivatives
07/15/2003US6593480 Obesity, hyperglycemia
07/15/2003US6593358 Method for controlling pests, comprising the step of allowing a pesticidally effective amount of one or more compounds selected from the group consisting of one or more compounds of the formula (Ia) according to claim 2 and one or compounds
07/15/2003US6593356 The present invention relates to the synthesis of a new class of indeno(1,2-c)pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and the
07/15/2003US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
07/15/2003US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases
07/15/2003US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof
07/15/2003US6593330 Compounds and their use
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man.
07/10/2003WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
07/10/2003WO2003055860A1 3,4-diarylpyrazoles and their use in the therapy of cancer
07/10/2003WO2003055489A1 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
07/10/2003WO2003055482A1 Amide derivatives as gk activators
07/10/2003WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
07/10/2003WO2003043987A3 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130505 Nonsteroidal agonists and antagonists
07/10/2003US20030130456 Vinyl group-containing diarylethene and polymer thereof having excellent optical properties
07/10/2003US20030130340 Novel benzothiophene derivatives
07/10/2003US20030130325 Substituted tryptophan derivatives
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3